Schedule 13D ownership disclosure

AUTOLUS THERAPEUTICS LTD

Security class unavailable · CUSIP: 05280R100

Event date: 2024-03-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,612,275
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-025536
Form type
SC 13D/A
Filer
Autolus Therapeutics plc
CIK
CIK 1730463
Filed
Mar 25, 2024
Reporting period
Mar 21, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub